| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3740269
[patent_doc_number] => 05753615
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-19
[patent_title] => 'Neuropeptides and their use as insecticides'
[patent_app_type] => 1
[patent_app_number] => 8/522326
[patent_app_country] => US
[patent_app_date] => 1995-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2849
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/753/05753615.pdf
[firstpage_image] =>[orig_patent_app_number] => 522326
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/522326 | Neuropeptides and their use as insecticides | Oct 31, 1995 | Issued |
Array
(
[id] => 4295666
[patent_doc_number] => 06184200
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-06
[patent_title] => 'Truncated glial cell line-derived neurotrophic factor'
[patent_app_type] => 1
[patent_app_number] => 8/535681
[patent_app_country] => US
[patent_app_date] => 1995-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 8
[patent_no_of_words] => 23005
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/184/06184200.pdf
[firstpage_image] =>[orig_patent_app_number] => 535681
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/535681 | Truncated glial cell line-derived neurotrophic factor | Sep 27, 1995 | Issued |
Array
(
[id] => 4323352
[patent_doc_number] => 06329158
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-11
[patent_title] => 'Use of dimly fluorescing nucleic acid dyes in the identification of nucleated cells'
[patent_app_type] => 1
[patent_app_number] => 8/528828
[patent_app_country] => US
[patent_app_date] => 1995-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 1627
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/329/06329158.pdf
[firstpage_image] =>[orig_patent_app_number] => 528828
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/528828 | Use of dimly fluorescing nucleic acid dyes in the identification of nucleated cells | Sep 14, 1995 | Issued |
Array
(
[id] => 3789657
[patent_doc_number] => 05840845
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-24
[patent_title] => 'Senescent cell derived inhibitors of DNA synthesis'
[patent_app_type] => 1
[patent_app_number] => 8/524218
[patent_app_country] => US
[patent_app_date] => 1995-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 10
[patent_no_of_words] => 11776
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/840/05840845.pdf
[firstpage_image] =>[orig_patent_app_number] => 524218
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/524218 | Senescent cell derived inhibitors of DNA synthesis | Sep 5, 1995 | Issued |
Array
(
[id] => 1478489
[patent_doc_number] => 06451763
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-17
[patent_title] => 'Retinal pigmented epithelium derived neurotrophic factor and methods of use'
[patent_app_type] => B1
[patent_app_number] => 08/520373
[patent_app_country] => US
[patent_app_date] => 1995-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40192
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/451/06451763.pdf
[firstpage_image] =>[orig_patent_app_number] => 08520373
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/520373 | Retinal pigmented epithelium derived neurotrophic factor and methods of use | Aug 28, 1995 | Issued |
Array
(
[id] => 4333176
[patent_doc_number] => 06313265
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-06
[patent_title] => 'Neurite outgrowth-promoting polypeptides containing fibronectin type III repeats and methods of use'
[patent_app_type] => 1
[patent_app_number] => 8/506296
[patent_app_country] => US
[patent_app_date] => 1995-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 58
[patent_no_of_words] => 57821
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/313/06313265.pdf
[firstpage_image] =>[orig_patent_app_number] => 506296
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/506296 | Neurite outgrowth-promoting polypeptides containing fibronectin type III repeats and methods of use | Jul 23, 1995 | Issued |
Array
(
[id] => 4239423
[patent_doc_number] => 06080720
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-06-27
[patent_title] => 'Treatment method of bone and osteoblasts with neurotrophin-3 (NT-3)'
[patent_app_type] => 1
[patent_app_number] => 8/505539
[patent_app_country] => US
[patent_app_date] => 1995-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2810
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/080/06080720.pdf
[firstpage_image] =>[orig_patent_app_number] => 505539
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/505539 | Treatment method of bone and osteoblasts with neurotrophin-3 (NT-3) | Jul 20, 1995 | Issued |
Array
(
[id] => 4216945
[patent_doc_number] => 06087331
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-11
[patent_title] => 'Therapeutic use of platelet-endothelial cell adhesion molecule-1 compositions'
[patent_app_type] => 1
[patent_app_number] => 8/478208
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15743
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/087/06087331.pdf
[firstpage_image] =>[orig_patent_app_number] => 478208
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/478208 | Therapeutic use of platelet-endothelial cell adhesion molecule-1 compositions | Jun 6, 1995 | Issued |
Array
(
[id] => 693887
[patent_doc_number] => 07070782
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-07-04
[patent_title] => 'Prostate-specific membrane antigen'
[patent_app_type] => utility
[patent_app_number] => 08/481916
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 17
[patent_no_of_words] => 12810
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/070/07070782.pdf
[firstpage_image] =>[orig_patent_app_number] => 08481916
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/481916 | Prostate-specific membrane antigen | Jun 6, 1995 | Issued |
| 08/487314 | HUMAN CALCIUM SENSOR PROTEIN, FRAGMENTS THEREOF AND DNA ENCODING SAME | Jun 6, 1995 | Abandoned |
Array
(
[id] => 4410515
[patent_doc_number] => 06239270
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-29
[patent_title] => 'Nucleic acids encoding human calcium sensor protein'
[patent_app_type] => 1
[patent_app_number] => 8/476515
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 68
[patent_figures_cnt] => 10
[patent_no_of_words] => 36790
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/239/06239270.pdf
[firstpage_image] =>[orig_patent_app_number] => 476515
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/476515 | Nucleic acids encoding human calcium sensor protein | Jun 6, 1995 | Issued |
| 08/477298 | PEPTIDE, IMMUNOGENIC COMPOSITIONS, VACCINES, AND MEDICINAL PREPARATIONS INCLUDING SAME; AND METHODS FOR IMMUNIZING A MAMMAL AGAINST LHRH, AND IMPROVING THE MEAT QUALITY OF PIGS | Jun 6, 1995 | Abandoned |
Array
(
[id] => 4270090
[patent_doc_number] => 06280732
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-28
[patent_title] => 'Methods of using an AL-1 neurotrophic factor immunoadhesin'
[patent_app_type] => 1
[patent_app_number] => 8/486449
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 23716
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/280/06280732.pdf
[firstpage_image] =>[orig_patent_app_number] => 486449
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/486449 | Methods of using an AL-1 neurotrophic factor immunoadhesin | Jun 6, 1995 | Issued |
Array
(
[id] => 1549781
[patent_doc_number] => 06399315
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-04
[patent_title] => 'Screening assays using cloned CRF receptors'
[patent_app_type] => B1
[patent_app_number] => 08/482746
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 27755
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 206
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/399/06399315.pdf
[firstpage_image] =>[orig_patent_app_number] => 08482746
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/482746 | Screening assays using cloned CRF receptors | Jun 6, 1995 | Issued |
| 08/483139 | CLONING AND RECOMBINANT PRODUCTION OF CRF RECEPTOR(S) | Jun 6, 1995 | Abandoned |
| 08/486448 | TGF-BETA TO IMPROVE NEURAL OUTCOME | Jun 6, 1995 | Abandoned |
Array
(
[id] => 3627478
[patent_doc_number] => 05621081
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-15
[patent_title] => 'Glial mitogenic factors'
[patent_app_type] => 1
[patent_app_number] => 8/471855
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 78
[patent_figures_cnt] => 89
[patent_no_of_words] => 35444
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/621/05621081.pdf
[firstpage_image] =>[orig_patent_app_number] => 471855
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/471855 | Glial mitogenic factors | Jun 5, 1995 | Issued |
Array
(
[id] => 4355847
[patent_doc_number] => 06190880
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-20
[patent_title] => 'Recombinant bone morphogenetic protein heterodimers, compositions and methods of use'
[patent_app_type] => 1
[patent_app_number] => 8/469411
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 14
[patent_no_of_words] => 19519
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/190/06190880.pdf
[firstpage_image] =>[orig_patent_app_number] => 469411
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/469411 | Recombinant bone morphogenetic protein heterodimers, compositions and methods of use | Jun 5, 1995 | Issued |
Array
(
[id] => 4403486
[patent_doc_number] => 06270998
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-07
[patent_title] => 'DNA coding for human cell surface antigen'
[patent_app_type] => 1
[patent_app_number] => 8/468560
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 18
[patent_no_of_words] => 13891
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/270/06270998.pdf
[firstpage_image] =>[orig_patent_app_number] => 468560
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/468560 | DNA coding for human cell surface antigen | Jun 5, 1995 | Issued |
Array
(
[id] => 408213
[patent_doc_number] => 07285531
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-10-23
[patent_title] => 'Method for prophylaxis or treatment of a nervous system, pathophysiological condition involving a glial growth factor sensitive cell by administration of a glial growth factor'
[patent_app_type] => utility
[patent_app_number] => 08/472065
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 78
[patent_figures_cnt] => 88
[patent_no_of_words] => 28039
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/285/07285531.pdf
[firstpage_image] =>[orig_patent_app_number] => 08472065
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/472065 | Method for prophylaxis or treatment of a nervous system, pathophysiological condition involving a glial growth factor sensitive cell by administration of a glial growth factor | Jun 5, 1995 | Issued |